Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species-sensitive mitochondrial components refer to a broad and heterogeneous group of molecules within the mitochondria—including proteins, lipids, and DNA—that are susceptible to oxidative modification or damage by reactive oxygen species (ROS). Key components often cited include the mitochondrial permeability transition pore (mPTP), respiratory chain complexes (particularly Complexes I and III), mitochondrial DNA (mtDNA), and redox-sensitive enzymes like aconitase. These components play a dual role: they are both sources of ROS and targets of ROS-mediated damage, which can lead to mitochondrial dysfunction, loss of membrane potential, and the initiation of apoptotic pathways. In various diseases such as neurodegeneration, heart failure, and diabetes, the pathological accumulation of ROS leads to the dysfunction of these components, making them a focus for therapeutic intervention. Drugs targeting these components typically include mitochondria-targeted antioxidants or stabilizers designed to preserve mitochondrial integrity and prevent cell death. However, because this term describes a collective group of structures rather than a single molecular entity, it is generally considered too broad to be a specific therapeutic target in drug discovery.
Mitochondrial-targeted antioxidants and inhibitors of the mitochondrial permeability transition pore (mPTP) aim to reduce oxidative damage or prevent the release of pro-apoptotic factors triggered by ROS-induced damage to mitochondrial components.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species-sensitive mitochondrial components (ROS-sensitive mitochondrial components).